-transparent.png){kind=logo}
Dexamethasone in form of its phosphate was given intravenously in two different doses (1.5 mg kg-1 and 15 mg). Plasma levels of the ester and dexamethasone were measured and pharmacokinetic parameters were calculated. The results indicate no dose-dependency of the pharmacokinetic parameters in the investigated range for dexamethasone. Conversion from the prodrug to the active form was rapid; maximum dexamethasone plasma concentrations were reached after 10 min. The results were verified by dexamethasone level monitoring in patients after chronic dosing. Predicted and achieved steady state levels agreed well.
Related Publications
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
January 2014,
PloS one,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
December 1988,
Neuropharmacology,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
October 2013,
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
January 2000,
Neurosurgery,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
April 2001,
Journal of clinical pharmacology,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
September 1975,
Clinical pharmacology and therapeutics,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
January 1986,
Ophthalmic research,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
January 1991,
European journal of drug metabolism and pharmacokinetics,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
September 1981,
British journal of clinical pharmacology,
P Rohdewald, and
H Möllmann, and
J Barth, and
J Rehder, and
H Derendorf
January 2005,
Inorganic chemistry,
